Exercise and Nutrition Support for Ovarian Cancer
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
Recruiting
N/A
Interventional Study
Ovarian Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 200 (estimated)
- Sponsor
- Yale University · Other
Who this trial is looking for
This trial is looking for women who have recently been diagnosed with ovarian or endometrial cancer and are starting chemotherapy. Participants will receive support for exercise and nutrition during their treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with stage I-IV ovarian cancer or advanced endometrial cancer.
- My treatment includes carboplatin and taxane.
- I am scheduled for at least 6 cycles of chemotherapy.
- I can walk without assistance.
- I can read and understand instructions in English or Spanish.
- I agree to be randomly assigned to either the exercise group or the control group.
- I have permission from my oncologist to participate.
- I am at least 18 years old.
You may not be able to join if
- I have already completed 2 cycles of chemotherapy.
- I have been following strict dietary guidelines with over 7 servings of fruits and vegetables daily.
- I have been exercising regularly with over 150 minutes per week of moderate to vigorous activity since my diagnosis.
- I am pregnant or planning to become pregnant.
- I had a stroke or heart attack in the last year.
- I have major psychiatric issues or dementia.
- I am receiving treatment for another cancer, except for hormone therapy.
- I am receiving external beam radiation.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
An anticipated 200 women with newly diagnosed ovarian and endometrial cancer scheduled to receive chemotherapy (adjuvant chemotherapy after surgery or neoadjuvant chemotherapy before surgery) will be recruited from Smilow Cancer Hospital Network at Yale Cancer Center (YCC) and Sylvester Comprehensive Cancer Center (SCCC) at University of Miami.
Participants will be randomized to an exercise and m…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* have a diagnosis of epithelial ovarian cancer, fallopian tube or primary peritoneal carcinoma, stage I-IV OR have a diagnosis of advanced or metastatic endometrial carcinoma (including carcinosarcoma) AND their treatment regimen includes carboplatin and taxane (or equivalent)
…
Contacts
No contact information available.